(A) Maximum z-projections of selected time points through the nuclear region of live starfish oocytes expressing H2B-mCherry (cyan) to label chromosomes during actin-driven chromosome congression. …
(A) Oocytes were injected with phalloidin-AlexaFluor 568 to label the initial contracting network ~ 2 min after the start of NEBD. Prior to injection, oocytes were centrifuged (bottom panel) in …
(A) A pulse of phalloidin-AlexaFluor 568 (red) was injected into the nuclear region ~2 min after NEBD in an oocyte expressing 3mEGFP-UtrCH (grays) to label the population of F-actin present at the …
(A) Schematics illustrating the expected response to ablation in case of a ‘pushing’ mechanism vs. active contraction of the network. (B) Selected sum-intensity z-projections through the nuclear …
Selected sum-intensity z-projections through the nuclear region of live oocytes expressing 3mCherry-UtrCH. One frame just before and frames after 3D ablation perpendicular to the animal-vegetal axis …
(A) Quantification of F-actin mass by measuring 3mEGFP- or 3mCherry-UtrCH intensities in the region corresponding to the old network (orange circle). Right: scheme illustrating extrapolation of the …
Quantification of F-actin density (mean fluorescence intensity) in the old network in different experiments: (A) in untreated control oocytes (related to Figure 4); (B) in oocytes injected with …
(A) Maximum-intensity z-projection through the nuclear region of oocytes expressing H2B-mCherry (cyan), either incubated for 3 hr with blebbistatin (300 μM), for 1 hr with ML-7 (100 μM) or Y-27632 …
(A) Selected frames from a time lapse of confocal sections through the nuclear region of live oocyte injected with DiIC16(3) to label endomembranes showing the absence of membranous structures in …
(A) Maximum-intensity z projections of the nuclear region of oocytes expressing H2B-mCherry (cyan) and injected with different amounts of recombinant UtrCH or PBS as control. Dashed circles …
(A) Model predictions for contraction rate, α0 as a function of the depolymerization rate k0 are compared to experimental data derived from oocytes injected with varying amounts of UtrCH. Top: 10 …
(A) Selected frames from a time lapse of confocal sections through the nuclear region of live oocytes expressing mEGFP3-UtrCH (gray). Oocytes were treated with either Latrunculin A (2.5 μM) or a …
Maximum z-projections of selected time points through the nuclear region of oocytes expressing mEGFP3-UtrCH (gray) and injected with H1-AlexaFluor 568 to visualize chromosomes (cyan). Latrunculin A …
(A) Top: schematic representation of the mechanism by a hypothetical end-tracking cross-linker serving as ‘depolymerization harnessing factor’. Bottom: zoom on two filaments linked by such …
(A) Selected snapshots of Cytosim simulations for different mechanisms of contraction. Actin filaments are shown in red. (B) Plot of the network radius over time for each simulation shown in (A). (C)…
(A) Maximum-intensity z-projection through the nuclear region of oocytes expressing H2B-mCherry (cyan), either incubated with DMSO or SMIFH2 (50 μM). Right: pseudocolored time projection of …
Oocyte expressing 3mEGFP-UtrCH (gray) was injected with phalloidin-AlexaFluor 568 to label the population of F-actin present at the time of injection. Scale bar: 20 μm.
3D laser ablation was performed in oocytes expressing mCherry3-UtrCH without (left) or with recombinant UtrCH-AlexaFluor 568 nm (right) injection. Scale bar: 20 μm.
Oocytes expressing 3mEGFP-UtrCH to visualize F-actin were acutely treated either with DMSO (left) or Latrunculin A (right). Scale bar: 20 μm.
Simulations show production of filaments (gray) while initially present filaments (red) are contracting to transport chromosomes (cyan).
Parameter name | Symbol | Model M | Model D |
---|---|---|---|
Elasticity | 2.1264 | 1.4778 | |
Contractility | 1.1961 | 1.3082 | |
Adhesion to boundary | ϵ | 0.6232 | 0.7838 |
Strain relaxation factor | 9.5898 | 2.3754 | |
Elastic power law exponent | 2 | 1 | |
Contractile power law exponent | m | 2 | 1 |
Viscous power law exponent | 1 | 1 |
UtrCH-stabilized | Lat A-treated* | SMIFH2-treated | ||||||
---|---|---|---|---|---|---|---|---|
Control | Low | Medium | High | Control | Lat A | Control | SMIFH2 | |
k0 | 0.162 | 0.126 | 0.073 | 0.048 | 0.0819 | 0.5106 | 0.1995 | 0.1650 |
0.677 | 0.889 | 6.946 | 709.4 | 0.0671 | 14.66 | 1.555 | 1.540 |
*The solvent, DMSO had an effect on the viscolelastic parameters even in controls (Supplementary file 3).
UtrCH injection | ||||
---|---|---|---|---|
Control | Low | Medium | High | |
Experiment | 0.0831 ± 0.012 | 0.0612 ± 0.011 | 0.0280 ± 0.006 | 0.0164 ± 0.005 |
Model M | 0.0818 | 0.1821 | 0.2063 | 0.2133 |
Model D | 0.0825 | 0.0586 | 0.0226 | 0.0117 |
Control | SMIFH2 | |
---|---|---|
Experiment | 0.086 ± 0.006 | 0.073 ± 0.007 |
Model M | 0.0859 | 0.1139 |
Model D | 0.0848 | 0.0675 |
Reagent type or resource | Designation | Source or reference |
---|---|---|
Biological sample | ||
Patiria miniata | Patiria miniata | https://scbiomarine.com/ |
Transfected construct | ||
MRLC (Patiria miniata) | MRLC-mEGFP | doi:10.1038/s41467-017-00979-6 |
H2B (human) | H2B-mCherry, H2B-3mEGFP | doi:10.1038/nmeth876 |
Utrophin CH domain (human) | mEGFP3-UtrCH, 3mCherry-UtrCH | doi:10.1002/cm.20226 |
myosinVb tail domain (mouse) | myosinVb-Tail | doi:10.1038/ncb2802 |
Peptide, recombinant protein | ||
Histone H1 (calf) | H1 | Merck |
Utrophin CH domain (human) | UtrCH | doi:10.1002/cm.20226 |
Commercial assay or kit | ||
AmpliCap-Max T7 High Yield Message Maker | AmpliCap-Max T7 High Yield Message Maker | CellScript |
Poly(A) tailing kit | Poly(A) tailing kit | CellScript |
Gel filtration column PD-10 | Gel filtration | GE Healthcare |
Ni-NTA resin | Ni-NTA resin | Qiagen |
Vivaspin column 10,000 MW | Vivaspin column | Sartorius |
Alexa Fluor 568 succinimidyl ester | Alexa Fluor 568 succinimidyl ester | Invitrogen |
Alexa Fluor 488 succinimidyl ester | Alexa Fluor 488 succinimidyl ester | Invitrogen |
Chemicals, drugs | ||
DiIC16(3) | DiI | Invitrogen |
1-methyladenine | 1-MA | ACROS organics |
Phalloidin-AlexaFluor 568 | Phalloidin-AlexaFluor 568 | Invitrogen |
LatrunculinA | Lat A | Abcam |
SMIFH2 | SMIFH2 | Tocris |
Y-27632 | Y-27632 | Enzo Life Sciences |
ML-7 | ML-7 | Tocris |
Blebbistatin | BB | Abcam |
Software, algorithm | ||
Matlab | Matlab | Mathworks |
Cytosim | Cytosim | doi:10.1088/1367-2630/9/11/427 |
Theory of the viscoelastic gel model for F-actin network.
Dimensionless viscoelastic parameters for UtrCH injections.
Dimensionless viscoelastic parameters for Latrunculin A treatments.
Dimensionless viscoelastic parameters for SMIFH2 treatments.
Cytosim configuration file to simulate a contracting F-actin network.
Matlab scripts used to analyze chromosome tracks.